Laxman Yetukur

Dr. Laxman Yetukur


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2016 in Viruses
Verified
Journal Article
Open access
PDF file
SSSandra Söderholm
Sandra Söderholm
YFYu Fu
Yu Fu
LGLana Gaelings
Lana Gaelings
SBSergei Belanov
Sergei Belanov
LYLaxman Yetukur
Laxman Yetukur
Denis KainovDenis Kainov
Denis Kainov
Human influenza A viruses (IAVs) cause global pandemics and epidemics. These viruses evolve rapidly, making current treatment options ineffective. To identify novel modulators of IAV–host interactions, we re-analyzed our recent transcriptomics, metabolomics, proteomics, phosphoproteomics, and genomics/virtual ligand screening data. We identified 713 potential modulators targeting 199 cellular and two viral proteins. Anti-influenza activity for 48 of them has been reported previously, whereas the antiviral efficacy of the 665 remains unknown. Studying anti-influenza efficacy and immuno/neuro-modulating properties of these compounds and their combinations as well as potential viral and host resistance to them may lead to the discovery of novel modulators of IAV–host interactions, which might be more effective than the currently available anti-influenza therapeutics.

5 August 2016 in Preprints.org
Verified
Preprint
Open access
PDF file
SSSandra Söderholm
Sandra Söderholm
YFYu Fu
Yu Fu
LGLana Gaelings
Lana Gaelings
SBSergey Belanov
Sergey Belanov
LYLaxman Yetukur
Laxman Yetukur
Denis KainovDenis Kainov
Denis Kainov
Human influenza A viruses (IAVs) cause global pandemics and epidemics. These viruses evolve rapidly, making current treatment options ineffective. To identify novel modulators of IAV-host interactions, we re-analyzed our recent transcriptomics, metabolomics, proteomics, phosphoproteomics, and genomics/virtual ligand screening data. We identified 713 potential modulators targeting 200 cellular and two viral proteins. Anti-influenza activity for 48 of them has been reported previously, whereas the antiviral efficacy of the remaining 665 is unknown. Studying anti-influenza efficacy, immuno-modulating properties and potential resistance of these compounds or their combinations may lead to the discovery of novel modulators of IAV-host interactions, which might be more effective than the currently available anti-influenza therapeutics.